Free Trial

CRISPR Therapeutics (CRSP) Insider Trading & Ownership

+0.55 (+1.00%)
(As of 09:04 AM ET)

CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$12.03 M
Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRSP Insider Buying and Selling by Quarter

CRISPR Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/15/2024Samarth KulkarniCEOSell19,582$59.91$1,173,157.62  
3/15/2024Raju PrasadCFOSell3,524$72.69$256,159.56  
3/15/2024Samarth KulkarniCEOSell20,000$72.48$1,449,600.00  
3/11/2024James R KasingerGeneral CounselSell2,801$78.26$219,206.26  
3/11/2024Samarth KulkarniCEOSell9,802$78.26$767,104.52  
2/20/2024James R KasingerGeneral CounselSell1,913$79.67$152,408.71  
2/20/2024Samarth KulkarniCEOSell6,370$79.67$507,497.90  
2/15/2024Samarth KulkarniCEOSell20,000$80.36$1,607,200.00  
1/29/2024Samarth KulkarniCEOSell50,000$60.51$3,025,500.00  
1/16/2024Samarth KulkarniCEOSell20,000$62.50$1,250,000.00  
5/30/2023Samarth KulkarniCEOSell25,000$64.88$1,622,000.00  
(Data available from 1/1/2013 forward)

CRSP Insider Trading Activity - Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R Kasinger, Michael John Tomsicek, Raju Prasad, Rodger Novak, and Samarth Kulkarni. Learn more on insiders at CRSP.

What percentage of CRISPR Therapeutics stock is owned by insiders?

4.10% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings.

Which CRISPR Therapeutics insiders have been selling company stock?

The following insiders have sold CRSP shares in the last 24 months: James R Kasinger ($371,614.97), Raju Prasad ($256,159.56), and Samarth Kulkarni ($26,741,310.04).

How much insider selling is happening at CRISPR Therapeutics?

Insiders have sold a total of 453,992 CRISPR Therapeutics shares in the last 24 months for a total of $27,369,084.57 sold.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:CRSP) was last updated on 5/28/2024 by Staff

From Our Partners